Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Noncontrolling Interests	Total
Balance at beginning of period at Dec. 31, 2019	$ 1,342	$ 3,633,042	$ (231,164)	$ (16,744)	$ 201	$ 3,386,677
Balance at beginning of period (in shares) at Dec. 31, 2019	134,148
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to common shareholders and noncontrolling interests			42,925			42,925
Conversion of common limited partnership units to common shares	$ 8	31,118				31,126
Conversion of common limited partnership units to common shares (in shares)	787
Common shares repurchased	$ (14)	(41,163)				(41,177)
Common shares repurchased (in shares)	(1,418)
Common shares issued pursuant to Employee Share Purchase Plan ("ESPP")		132				132
Contributions from noncontrolling interests, net					2	2
Redeemable noncontrolling interests redemption value adjustment and other comprehensive income (loss) allocation		100,666		3,573		104,239
Other comprehensive income (loss)				(32,770)		(32,770)
Balance at end of period (in shares) at Mar. 31, 2020	133,517
Balance at end of period at Mar. 31, 2020	$ 1,336	3,723,795	(188,239)	(45,941)	203	3,491,154
Balance at beginning of period at Dec. 31, 2020	$ 1,319	3,657,643	(412,944)	(39,979)	167	$ 3,206,206
Balance at beginning of period (in shares) at Dec. 31, 2020	131,778					131,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to common shareholders and noncontrolling interests			(20,731)		(1,108)	$ (21,839)
Conversion of common limited partnership units to common shares	$ 1	3,918				3,919
Conversion of common limited partnership units to common shares (in shares)	119
Common shares repurchased	$ (6)	(19,197)				(19,203)
Common shares repurchased (in shares)	(620)
Common shares issued pursuant to employee incentive compensation plan and Employee Share Purchase Plan ("ESPP")		249				249
Contributions from noncontrolling interests, net					9,671	9,671
Redeemable noncontrolling interests redemption value adjustment and other comprehensive income (loss) allocation		(11,336)		(973)		(12,309)
Other comprehensive income (loss)				10,152		$ 10,152
Balance at end of period (in shares) at Mar. 31, 2021	131,277					131,277
Balance at end of period at Mar. 31, 2021	$ 1,314	$ 3,631,277	$ (433,675)	$ (30,800)	$ 8,730	$ 3,176,846